Proteolysis of insulin-like growth factor binding proteins by a novel 50-kilodalton metalloproteinase in human pregnancy serum

Endocrinology

Volumn 139, Issue 4, 1998, Pages 1556-1563

  Kübler, Bernd ^a   Cowell, Susan ^b   Zapf, Jürgen ^c   Braulke, Thomas ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

METALLOPROTEINASE; SOMATOMEDIN BINDING PROTEIN;

ARTICLE; ENZYME ACTIVITY; ENZYME PURIFICATION; ENZYME SPECIFICITY; FETUS GROWTH; GEL PERMEATION CHROMATOGRAPHY; HUMAN; IMMUNOBLOTTING; MOLECULAR WEIGHT; PLACENTA DEVELOPMENT; PREGNANCY; PRIORITY JOURNAL; PROTEIN DEGRADATION; SERUM;

EID: 0031763483     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.4.5872     Document Type: Article

References (44)

1. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
2. Zapf J 1995 Physiological role of the insulin-like growth factor binding proteins. Eur J Endocrinol 132:645-654
3. Baxter RC 1993 Circulating binding proteins for the insulinlike growth factors. Trends Endocrinol Metab 4:91-96
4. Fielder PJ, Guevera-Aguirre J, Rosenbtoom AL, Carlsson L, Hintz RL, Rosenfeld RG 1992 Expression of serum insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs) and the growth hormone-binding protein (GHBP) in heterozygote relatives of Ecuadorian GH-receptor deficient patients. J Clin Endocrinol Metab 74:743-750
5. Bang P, Brismar K, Rosenfeld RG 1994 Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130-to 150-kDa ternary complex. J Clin Endocrinol Metab 78:1119-1127
6. Davenport ML, Isley WL, Pucilowska JB, Pemberton LB, Lyman B, Underwood LE, Clemmons DR 1992 Insulin-like growth factor-binding protein-3 proteolysis is induced after elective surgery. J Clin Endocrinol Metab 75:590-595
7. Hossenlopp P, Segovia B, Lassarre C, Rughani M, Bredon M, Binoux M 1990 Evidence of enzymic degradation of insulin-like growth factor-binding proteins in the 150 K complex during pregnancy. J Clin Endocrinol Metab 71:797-805
8. Giudice LC, Farrell EM, Pham H, Lamson G, Rosenfeld RG 1990 Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: effects of a pregnancy-associated serum protease activity. J Clin Endocrinol Metab 71:806-816
9. Gargorsky SE, Owens PC, Walton PE, Owens JA, Robinson JS, Wallace JC, Ballard FJ 1991 Most of the circulating insulin-like growth factors-I and -II are present in the 150 kDa complex during human pregnancy. J Endocrinol 131:491-497
10. Suikkari A-M, Baxter RC 1992 Insulin-like growth factor-binding protein-3 is functionally normal in pregnancy serum. J Clin Endocrinol Metab 74:177-183
11. Lassarre C, Binoux M 1994 Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma Endocrinology 134:1254-1262
12. Davenport ML, Clemmons DR, Miles MV, Camacho-Hubner C, D'Ercole AJ, Underwood LE 1990 Regulation of serum insulin-like growth factor-I (IGF-I) and IGF binding proteins during rat pregnancy. Endocrinology 127:1278-1286
13. Blat C, Villandy J, Binoux M 1994 In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. J Clin Invest 93:2286-2290
14. Claussen M, Zapf J, Braulke T 1994 Proteolysis of insulin-like growth factor binding protein-5 by pregnancy serum and amniotic fluid. Endocrinology 134:1964-1966
15. Fowlkes JL, Suzuki K, Nagase H, Thrailkill KM 1994 Proteolysis of insulin-like growth factor binding protein-3 during rat pregnancy: a role for matrix metalloproteinases. Endocrinology 135:2810-2813
16. Kiefer MC, Schmid C, Waldvogel M, Schlapf er I, Futo E, Masciarz FR, Green K, Barr PJ, Zapf J 1992 Characterization of recombinant human insulin-like growth factor binding proteins 4, 5, and 6 produced in yeast. J Biol Chem 267:12692-12699
17. Parker KC, Strominger JC 1983 Localization of the sites of iodination of human β2-microglobulin: quaternary structure implications for histocompatibility antigens. Biochemistry 22:1145-1153
18. Willenbrock F, Crabbe T, Slocombe PM, Sutton CW, Docherty AJP, Cockert MI, O'Shea M, Brocklehurst K, Phillips IR, Murphy G 1993 The activity of the tissue inhibitor of metalloproteinases is regulated by C-terminal domain interactions, a kinetic analysis of the inhibition of gelatinase A. Biochemistry 32:4330-4337
19. Mohler KM, Sleath PR, Fitzner JN, Cerretti DP, Alderson M, Kerwar SS, Torrance DS, Otten-Evans C, Greenstreet T, Weerawarna K, Kronheim SR, Petersen M, Gerhart M, Kozlosky CJ, March CJ, Black RA 1994 Protection against a lethal dose of endotoxin by an inhibitor of rumour necrosis factor processing. Nature 370:218-220
20. Hembry RM, Bagga MR, Reynolds JJ, Hamblen DL1995 Immunolocalization studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis. Ann Rheum Dis 54:25-32
21. Hipps DS, Hembry RM, Docherty AJP, Reynolds JJ, Murphy G 1991 Purification and characterization of human 72-kDa gelatinase (type IV collagenase). Use of immunolocalization to demonstrate the non-coordinated regulation of the 72-kDa and 95-kDa gelatinases by human fibroblasts. Biol Chem Hoppe-Seyler 372:287-296
22. Allan JA, Hembry RM, Angal S, Reynolds JJ, Murphy G 1991 Binding of latent and high Mr active forms of stromelysin to collagen is mediated by the C-terminal domain. J Cell Sci 99:789-795
23. Murphy G, Ward R, Hembry RM, Reynolds JJ, Kuhn K, Tryggvason K 1989 Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagervase. Biochem J 258:463-472
24. Knäuper V, Will H, Lopez-Otin C, Smith B, Atkinson SJ, Stanton H, Hembry RM, Murphy G 1996 Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme. J Biol Chem 271:17124-17131
25. Howard L, Lu X, Mitchell S, Griffiths S, Glynn P 1996 Molecular cloning of MADM: a catalytically active mammalian disintegrin-metalloprotease expressed in various cell types. Biochem J 317:45-50
26. Heussen C, Dowdle EB 1980 Electrophoretic analysis of plasminogen activation in polyacrylamide gels containing sodium dodecylsulfate and copolymerized substrates. Anal Biochem 102:196-202
27. Fowlkes JL, Enghild JJ, Suzuki K, Nagase H 1994 Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. J Biol Chem 269:25742-25746
28. Parker A, Gockerman A, Busby WH, Clemmons DR 1995 Properties of an insulin-like growth factor-binding protein-4 protease that is secreted by smooth muscle cells. Endocrinology 136:2470-2476
29. Thrailkill KM, Quarles P, Nagase H, Suzuki K, Serra DM, Fowlkes JL 1995 Characterization of insulin-like growth factor-binding protein 5-degrading proteases produced throughout murine osteoblast differentiation. Endocrinology 136:3527-3533
30. Murphy G, Crabbe T 1995 Gelatinases A and B. Methods Enzymol 248:470-484
31. Gearing AJH, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon JL, Leber TM, Mangan M, Miller K, Nayee P, Owen K, Patel S, Thomas W, Wells G, Wood LM, Woolley K 1994 Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature 370:555-557
32. Black RA, Durie FH, Otten-Evans C, Miller R, Slack JL, Lynch DH, Cashier B, Mohler KM, Gerhart M, Johnson RS, Itoh Y, Okada Y, Nagase H 1996 Relaxed specificity of matrix metalloproteinases (MMPs) and TIMP insensitivity of tumor necrosis factor-α (TNF-α) production suggest the major TNF-α converting enzyme is not an MMP. Biochem Biophys Res Commun 225:400-405
33. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Ceretti DP 1997 A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature 385:729-733
34. Moss ML, Jin SLC, Milla ME, Burkhart W, Carter HL, Cheen WJ, Clay WC, Didsbury JR, Hassler D, Hoffman CR, Kost TA, Lambert MH, Leesnitzer MA, McCauley P, McGeehan G, Mitchell J, Moyer M, Pahel G, Rocque W, Overton LK, Schoenen F, Seaton T, Su JL, Warner J, Willard D, Becherer D 1997 Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature 385:733-736
35. Wolfsberg TG, White JM 1996 ADAMs in fertilization and development. Develop Biol 180:389-401
36. Emi M, Katagiri T, Harada Y, Saito H, Inazawa J, Ito I, Kasumi F, Nakamura Y 1993 A novel metalloprotease/disintegrin-like gene at 17q21.3 is somatically rearranged in two primary breast cancers. Nature Genet 5:151-157
37. Shannon JD., Baramova EN, Bjarnason JB, Fox JW 1989 Amino acid sequence of a Crotalus atrox venom metalloproteinase which cleaves type IV collagen and gelatin. J Biol Chem 264:11575-11583
38. Nam TJ, Busby WH, Clemmons DR 1996 Characterization and determination of the relative abundance of two types of insulin-like growth factor binding protein-5 proteases that are secreted by human fibroblasts. Endocrinology 137:5530-5536
39. Cohen P, Graves HC, Peehl DM, Kamarei M, Guidice LC, Rosenfeld RG 1992 Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab 75:1046-1053
40. Campbell PG, Novak JF, Yanosick TB, McMaster JH 1992 Involvement of the plasmin system in dissociation of the insulin-like growth factor-binding protein complex. Endocrinology 130:1401-1412
41. Lalou C, Silve C, Rosato R, Segovia B, Binoux M 1994 Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein-3 production and proteolysis in human osteosarcoma cells. Endocrinology 135:2318-2326
42. Bang P, Fielder PJ 1997 Human pregnancy serum contains at least two distinct proteolytic activities with the ability to degrade insulin-like growth factor binding protein-3. Endocrinology 138:3912-3917
43. Bang P, Westgren M, Schwander J, Blum WF, Rosenfeld RG, Stangenberg M 1994 Ontogeny of insulin-like growth factor-binding protein-1, -2, and -3: quantitative measurements by radioimmunoassay in human fetal serum. Peditr Res 36:528-536
44. Vettraino IM, Roby J, Tolley T, Parks WC 1996 Collagenase-I, stromelysin-I, and matrilysin are expressed within the placenta during multiple stages of human pregnancy. Placenta 17:557-563